Recent Articles

April 14, 2015 8:49 am
Ryan Bushey, Associate Editor
Shortcomings in the fast-evolving digital health care arena are becoming obvious. Read more...
April 13, 2015 3:47 pm
Drug Discovery & Development Staff
Coffee drinking is often associated with lower rates of degenerative diseases, from Parkinson’s to cancers. Two recent studies support one theory why: coffee protects DNA from breaking, and quite shortly after it is consumed.
April 13, 2015 1:20 pm
Ryan Bushey, Associate Editor
Investors and financial analysts are worried about this decision. Read more...
April 9, 2015 12:07 pm
Cynthia Fox, Science Writer
The first personalized cancer vaccine using genomics to define targets elicits robust immune responses, says a recent Science study. Read more...
April 7, 2015 5:17 pm
Cynthia Fox, Science Editor
Two recent studies have concluded that tau, not amyloid, is the main driver behind Alzheimer’s disease (AD). Read more...
April 7, 2015 2:46 pm
Adam Dion, Healthcare Industry Analyst, GlobalData
The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014. Read more...
April 7, 2015 2:29 pm
Ryan Bushey, Associate Editor
This brings the total funding for the Boston-based startup to 8.8 million. Read more...
April 7, 2015 11:49 am
Ryan Bushey, Associate Editor
This program will utilize a precision medicine approach to potentially find a cure for this disease. Read more...
April 6, 2015 4:26 pm
Bill Sawka, MicroCal Product Manager, Malvern Instruments & Natalia Markova, Principal Scientist – MicroCal, Malvern Instruments
Isothermal titration calorimetry (ITC) is a highly valuable technique that is used throughout drug discovery workflow to study the binding interactions of proteins and small molecules. It is an essential tool for both drug design and the study and regulation of protein interactions. Read more...
April 2, 2015 11:21 am
Cynthia Fox, Science Writer
As a patient prepares to become the first in history to receive his own genetically engineered stem cells for sickle cell disease, two top scientists are already improving the approach. Read more...
Subscribe to Drug Discovery & Development